Koshinski Asset Management, Inc. Immuno Gen, Inc. Transaction History

Koshinski Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$3.15 - $5.76 $5,109 - $9,342	-1,622 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$4.26 - $7.48 $85 - $149	-20 Reduced 1.22%	1,622 $7.72 Million
Q4 2021 Jan 14, 2022	BUY	$4.75 - $7.5 $123 - $195	26 Added 1.61%	1,642 $12.2 Million
Q3 2021 Oct 12, 2021	BUY	$5.02 - $6.59 $8,112 - $10,649	1,616 New	1,616 $9,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.